NCT02232893 - Effect of TU-100 in Patients Undergoing Laparoscopic Colectomy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions

Postoperative Ileus

Interventions

DRUG

Daikenchuto (TU-100)

Subjects will receive 5g TID (15g/day) of TU-100. Dosage form is granule. Subject will take a daily dose divided 3 times per day for 3 days before surgery and for 28 days after surgery.

DRUG

Placebo

Subjects will receive daily dose of TU-100 placebo. Dosage form is granule. Subject will take a daily dose divided 3 times per day for 3 days before surgery and for 28 days after surgery.

Trial Locations (13)

30342

Atlanta Site, Atlanta

33331

Weston Site, Weston

39042

Jackson Site, Jackson

44106

Cleveland Site, Cleveland

55407

Minneapolis Site, Minneapolis

55433

Coon Rapids Site, Coon Rapids

60637

Chicago Site, Chicago

70006

Metairie Site, Metairie

80045

Aurora Site, Aurora

90048

Los Angeles Site, Los Angeles

99204

Spokane Site, Spokane

01805

Burlington, MA Site, Burlington

05401

Burlington, VT Site, Burlington